Jieqiong Peng

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Deficiency of LAMP2A in macrophages accelerates hypoxia-induced atherosclerosis by inhibiting BNIP3-mediated mitophagy.

Deficiency of LAMP2A in macrophages accelerates hypoxia-induced atherosclerosis by inhibiting BNIP3-mediated mitophagy.

Journal: International immunopharmacology

Published: December 11, 2025

Case Report: Sustained complete response achieved in a patient with advanced HER-2 positive gastric cancer after 4 years of chemotherapy-free treatment.

Case Report: Sustained complete response achieved in a patient with advanced HER-2 positive gastric cancer after 4 years of chemotherapy-free treatment.

Journal: Frontiers in oncology

Published: November 28, 2025

Development and validation of a prognostic model for first-line immunotherapy for metastatic esophageal squamous cell carcinoma.

Development and validation of a prognostic model for first-line immunotherapy for metastatic esophageal squamous cell carcinoma.

Journal: International immunopharmacology

Published: September 16, 2025

TRP-related gene signatures predict survival and the immune microenvironment in rectal cancer: a comprehensive bioinformatics study.

TRP-related gene signatures predict survival and the immune microenvironment in rectal cancer: a comprehensive bioinformatics study.

Journal: Frontiers in immunology

Published: April 02, 2025

Deficient chaperone-mediated autophagy in macrophages aggravates colitis and colitis-associated tumorigenesis in mice.

Deficient chaperone-mediated autophagy in macrophages aggravates colitis and colitis-associated tumorigenesis in mice.

Journal: Molecules and cells

Published: December 27, 2024

PD-1 inhibitor combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma patients with distant metastasis: a real-world retrospective study.

PD-1 inhibitor combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma patients with distant metastasis: a real-world retrospective study.

Journal: Frontiers in immunology

Published: December 10, 2023

Efficacy and safety of sintilimab combined with apatinib as third-line or above therapy for patients with advanced or metastatic gastric cancer.

Efficacy and safety of sintilimab combined with apatinib as third-line or above therapy for patients with advanced or metastatic gastric cancer.

Journal: Anti-cancer drugs

Published: November 10, 2023

Comparison of the efficacy and safety of third-line treatments for metastatic colorectal cancer: a systematic review and network meta-analysis.

Comparison of the efficacy and safety of third-line treatments for metastatic colorectal cancer: a systematic review and network meta-analysis.

Journal: Frontiers in oncology

Published: July 29, 2023

LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.

LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles.

Journal: Autophagy

Published: July 20, 2023

Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review.

Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review.

Journal: Medicine

Published: January 10, 2023

Patients with positive HER-2 amplification advanced gastroesophageal junction cancer achieved complete response with combined chemotherapy of AK104/cadonilimab (PD-1/CTLA-4 bispecific): A case report.

Patients with positive HER-2 amplification advanced gastroesophageal junction cancer achieved complete response with combined chemotherapy of AK104/cadonilimab (PD-1/CTLA-4 bispecific): A case report.

Journal: Frontiers in immunology

Published: September 20, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026